Phage display and bacterial expression of a recombinant Fab specific for Pseudomonas aeruginosa serotype O6 lipopolysaccharide.
Immunotherapy with antibodies (Abs) against the lipopolysaccharide (LPS) of Pseudomonas aeruginosa remains an alternative to serotype-specific LPS-based vaccines due to their limited use and to antibiotics due to the intrinsic resistance to antimicrobials observed in P. aeruginosa. We have chosen a...
Gardado en:
| Publicado en: | Clin Diagn Lab Immunol |
|---|---|
| Principais autores: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
American Society for Microbiology (ASM)
1997
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC170494/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/9067648/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/cdli.4.2.147-155.1997 |
| Tags: |
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|